{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:12:23Z","timestamp":1790622743109,"version":"4.1.0"},"reference-count":69,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cannabis &amp; Cannabinoid Research"],"published-print":{"date-parts":[[2021,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>\n                      Overdose fatalities associated with the opioid epidemic are predictably attributable to drug-induced respiratory depression. In terms of illicit opioid abuse, fentanyl is the synthetic opioid responsible for the largest number of overdose deaths. There is, therefore, an urgent need to identify safe and effective therapeutics that can attenuate fentanyl-induced respiratory depression. Identification of effective alternate analgesic strategies that lessen the respiratory depression associated with narcotics would also help improve current strategies for pain management. Our laboratory recently reported that the G protein-biased CB\n                      <jats:sub>2<\/jats:sub>\n                      cannabinoid receptor agonist LY2828360 suppressed chemotherapy-induced neuropathic nociception and attenuated both morphine tolerance and physical dependence in paclitaxel-treated mice. However, the impact of LY2828360 on other undesirable side effects of opioids, such as opioid-induced respiratory depression, remains unknown.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      We used whole-body plethysmography to assess the impact of the CB\n                      <jats:sub>2<\/jats:sub>\n                      cannabinoid agonist LY2828360 on fentanyl-induced respiratory depression using wild-type (WT) and CB\n                      <jats:sub>2<\/jats:sub>\n                      knockout (CB\n                      <jats:sub>2<\/jats:sub>\n                      KO) mice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Fentanyl reduced minute ventilation and respiratory frequency without altering tidal volume in both WT and CB\n                      <jats:sub>2<\/jats:sub>\n                      KO mice. In WT mice, the high dose of fentanyl (0.2\u2009mg\/kg intraperitoneal [i.p.]) produced a greater suppression of respiratory parameters compared with the low dose of fentanyl (0.1\u2009mg\/kg i.p.). Coadministration of a behaviorally active dose of LY2828360 (3\u2009mg\/kg i.p.) with fentanyl (0.2\u2009mg\/kg i.p.) attenuated fentanyl-induced respiratory depression in WT mice. Notably, LY2828360 (3\u2009mg\/kg i.p.) did not attenuate fentanyl-induced respiratory depression in CB\n                      <jats:sub>2<\/jats:sub>\n                      KO mice, consistent with mediation by CB\n                      <jats:sub>2<\/jats:sub>\n                      receptors. Moreover, LY2828360 (3\u2009mg\/kg i.p.) alone lacked intrinsic effects on respiratory parameters in either WT or CB\n                      <jats:sub>2<\/jats:sub>\n                      KO mice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      The combination of a CB\n                      <jats:sub>2<\/jats:sub>\n                      agonist with fentanyl may represent a safer adjunctive therapeutic strategy compared with a narcotic analgesic alone by attenuating the development of opioid-induced respiratory depression. Moreover, the CB\n                      <jats:sub>2<\/jats:sub>\n                      agonist, administered alone, did not alter respiration. Our findings suggest that the CB\n                      <jats:sub>2<\/jats:sub>\n                      cannabinoid agonist LY2828360 may provide CB\n                      <jats:sub>2<\/jats:sub>\n                      -mediated protection against fentanyl-induced respiratory depression, a detrimental and unwanted side effect of opioid use and abuse.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/can.2020.0059","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T10:45:30Z","timestamp":1603363530000},"page":"389-400","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Cannabinoid CB\n                    <sub>2<\/sub>\n                    Receptor Activation Attenuates Fentanyl-Induced Respiratory Depression"],"prefix":"10.1177","volume":"6","author":[{"given":"Carmen A.","family":"Zavala","sequence":"first","affiliation":[{"name":"Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Thomaz","sequence":"additional","affiliation":[{"name":"Genome, Cell, and Developmental Biology Program, Indiana University, Bloomington, Indiana, USA."},{"name":"Program in Neuroscience, Indiana University, Bloomington, Indiana, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishakh","family":"Iyer","sequence":"additional","affiliation":[{"name":"Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana, USA."},{"name":"Program in Neuroscience, Indiana University, Bloomington, Indiana, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Mackie","sequence":"additional","affiliation":[{"name":"Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana, USA."},{"name":"Genome, Cell, and Developmental Biology Program, Indiana University, Bloomington, Indiana, USA."},{"name":"Program in Neuroscience, Indiana University, Bloomington, Indiana, USA."},{"name":"Gill Center for Biomolecular Science, Indiana University, Bloomington, Indiana, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea G.","family":"Hohmann","sequence":"additional","affiliation":[{"name":"Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana, USA."},{"name":"Genome, Cell, and Developmental Biology Program, Indiana University, Bloomington, Indiana, USA."},{"name":"Program in Neuroscience, Indiana University, Bloomington, Indiana, USA."},{"name":"Gill Center for Biomolecular Science, Indiana University, Bloomington, Indiana, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,10,13]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6911a4"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6910a4"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6634a2"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2018.05.042"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bku086"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14860"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aen094"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2016.1157722"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6614a2"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/acem.13034"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.06.005"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/2042098617744161"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6533a3"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/15563650701877374"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0013-12.2012"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3475-14.2014"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1089\/can.2018.0022"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00571.2015"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2017.02.011"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705422"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705874"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-003-0787-3"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(24)37642-6"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1995.tb20780.x"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(97)82001-3"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1006\/taap.1996.8034"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1369.052"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2005.03380.x"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2003.02704.x"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2005.06.009"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1115740"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2005.11.035"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/365061a0"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4230"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.117.109355"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.118.113233"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1177\/1744806917728227"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2016.12.008"},{"key":"e_1_3_3_40_2","first-page":"S56","article-title":"A proof-of-concept (POC) study including experimental pain models (EPMs) to assess the effects of a CB2 agonist (LY2828360) in the treatment of patients with osteoarthritic (OA) knee pain","volume":"93","author":"Pereira A","year":"2013","unstructured":"Pereira A, , Chappell A, , Dethy J, et al. A proof-of-concept (POC) study including experimental pain models (EPMs) to assess the effects of a CB2 agonist (LY2828360) in the treatment of patients with osteoarthritic (OA) knee pain. Clin Pharmacol Ther. 2013; 93:S56\u2013S57.","journal-title":"Clin Pharmacol Ther"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2015.201"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/48.11.1039"},{"key":"e_1_3_3_43_2","unstructured":"Motulsky H. Intuitive biostatistics: a nonmathematical guide to statistical thinking. Oxford University Press: New York 2010."},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm675152e1"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2018.05.041"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2007.06.040"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FP0050171"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1988.tb11661.x"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(25)20030-1"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705435"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/35040576"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2009.08.002"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00534.2014"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2008.07.008"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2004.05.038"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1203\/01.pdr.0000228839.00122.6c"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2006.10.053"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2012.01948.x"},{"key":"e_1_3_3_59_2","first-page":"277","article-title":"NOX2 is involved in CB2-mediated protection against lung ischemia-reperfusion injury in mice","volume":"13","author":"Huang W","year":"2020","unstructured":"Huang W, , Xiong Y, , Chen Y, et al. NOX2 is involved in CB2-mediated protection against lung ischemia-reperfusion injury in mice. Int J Clin Exp Pathol. 2020; 13:277\u2013285.","journal-title":"Int J Clin Exp Pathol"},{"key":"e_1_3_3_60_2","first-page":"4096","article-title":"Activation of cannabinoid receptor type 2 reduces lung ischemia reperfusion injury through PI3K\/Akt pathway","volume":"12","author":"Zeng J","year":"2019","unstructured":"Zeng J, , Li X, , Cheng Y, et al. Activation of cannabinoid receptor type 2 reduces lung ischemia reperfusion injury through PI3K\/Akt pathway. Int J Clin Exp Pathol. 2019; 12:4096\u20134105.","journal-title":"Int J Clin Exp Pathol"},{"key":"e_1_3_3_61_2","first-page":"971750","article-title":"CB2 receptor activation ameliorates the proinflammatory activity in acute lung injury induced by paraquat","volume":"2014","author":"Liu Z","year":"2014","unstructured":"Liu Z, , Wang Y, , Zhao H, et al. CB2 receptor activation ameliorates the proinflammatory activity in acute lung injury induced by paraquat. Biomed Res Int. 2014; 2014:971750.","journal-title":"Biomed Res Int"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.17070808"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(01)00369-4"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001010050390"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1177\/026921639601000208"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2005.01.012"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1111\/add.13027"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.6.2.125"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.087254"},{"key":"e_1_3_3_70_2","doi-asserted-by":"crossref","unstructured":"Kliewer A Gillis A Hill R et al. Morphine-induced respiratory depression is independent of beta-arrestin2 signalling. Br J Pharmacol. 2020 [Epub ahead of print]; DOI: 10.1111\/bph.15004.","DOI":"10.1111\/bph.15004"}],"container-title":["Cannabis &amp; Cannabinoid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/can.2020.0059","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2020.0059","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/can.2020.0059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:11:10Z","timestamp":1777385470000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/can.2020.0059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10,1]]}},"alternative-id":["10.1089\/can.2020.0059"],"URL":"https:\/\/doi.org\/10.1089\/can.2020.0059","relation":{},"ISSN":["2578-5125","2378-8763"],"issn-type":[{"value":"2578-5125","type":"print"},{"value":"2378-8763","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,1]]}}}